Patch Test Skin Irritation/Sensitization of Cetaphil Daily Advance Ultra Hydration Lotion

Galderma logo

Galderma

Status

Completed

Conditions

Determine Sensitivity of Skin to Cetaphil Daily Advance Ultra Hydrating Lotion

Treatments

Other: Cetaphil Daily Advance Ultra Hydrating Lotion

Study type

Interventional

Funder types

Industry

Identifiers

NCT01885130
GLI.04.SRE.US10232a

Details and patient eligibility

About

Determine if Cetaphil Daily Advance Ultra Hydrating Lotion proves to be a contact sensitizer or irritant in certain individuals.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

* Not currently under a doctor's care * Free of dermatological or systemic disorder which would interfere with the results * Free of any acute or chronic disease * Will complete a preliminary medical history form and are in general good health * Can read, understand, and sign informed consent

Exclusion criteria

* Under 18 years old * Currently under doctor's care * currently taking any medication * History of acute or chronic disease * Diagnosed with chronic skin allergies * Pregnant or lactating

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

Cetaphil Daily Advance Ultra Hydrating Lotion
Experimental group
Description:
All subjects receive Cetaphil Daily Advance Ultra Hydrating Lotion
Treatment:
Other: Cetaphil Daily Advance Ultra Hydrating Lotion

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems